CNTN2 and Parkinson disease: To our knowledge, CSF contactin-2 levels have not been investigated in PD patients before, although a proteomics-based study found a tendency towards lower levels of contactin-2 in the post-mortem prefrontal cortex of PD patients, compared to controls [20].